Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study

Abstract Background A post hoc analysis of the STAR study, which was a 48-week, phase IV, multicenter randomized controlled multicenter clinical trial was performed. This study aims to identify the baseline factors associated with visual and anatomic changes over 48 weeks in the treatment of active...

Full description

Bibliographic Details

Published in:	Eye and Vision
Main Authors:	Tsung-I. Wang, Jinfeng Qu, Ran Tang, Xuan Shi, Xin Ying, Ye Tao, Xiaoxin Li
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Subjects:	Anti-vascular endothelial growth factor Conbercept Polypoidal choroidal vasculopathy Neovascular age-related macular degeneration Treat-and-extend
Online Access:	https://doi.org/10.1186/s40662-025-00441-5